604 top medical experts on Pulmonary Sarcoidosis across 36 countries and 35 U.S. states, including 525 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pulmonary Sarcoidosis: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Interstitial Lung Diseases (4,640), Sarcoidosis (3,491).
  4. Clinical Trials ClinicalTrials.gov : at least 49 including 1 Active, 20 Completed, 11 Recruiting


  

        

                    


    Computing Expert Listing ...

);